Healthcare costs

Employers have an opportunity to help employees make better decisions about retirement savings to address out-of-control medical costs.

With the updates to Medicare after the passing of the Affordable Care Act prescription drug cost is running rampant due to the inability to negotiate price and the lack of benchmarks for stability.

The DOL upended the traditional dynamic of company-sponsored benefits and threw a lifeline to millions of small companies and their HR teams.

Attempting to circumvent the costly specialty drug chain, brokers are encouraging clients to shop for FDA-approved drugs outside the U.S.

Even high-net-worth clients are reluctant to discuss LTC planning, a new survey finds.

The health venture established will take aim at intermediaries in the healthcare system as a part of a broad effort to reduce wasteful spending

Advisors should frame health care costs as an annual expense rather than a lump sum, which is demotivating for investors, according to Vanguard.

The world’s biggest pharmaceutical companies, looking to sell a new type of cancer drug that could transform treatment, are grappling with an unusual challenge: finding patients.

The CEO of the Amazon-JPMC-Berkshire Hathaway aims to address the “tapeworm” eating the U.S. economy.

By continually reviewing prescription benefit policies and adapting them to current clinical information, employees are limited to their first exposure to addictive painkillers.